Surgical treatment of the neuroischemic foot

Journal of Cardiovascular Surgery

Volumn 50, Issue 3, 2009, Pages 293-311

  Simms, M ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Diabetic neuropathies; Foot ulcer

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ENOXAPARIN; PAPAVERINE; PROSTACYCLIN DERIVATIVE;

ANGIOPLASTY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ATHEROSCLEROSIS; CLINICAL ASSESSMENT; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ECHOGRAPHY; ENDOVASCULAR SURGERY; FOOT AMPUTATION; GANGRENE; GRAFT PATENCY; HEALTH SERVICE; HUMAN; INFECTION; LIMB SALVAGE; NEUROPATHIC JOINT DISEASE; PATIENT EDUCATION; PERIPHERAL ISCHEMIA; REVIEW; SURVIVAL RATE; VASOSPASM; VEIN THROMBOSIS;

AMPUTATION; COMBINED MODALITY THERAPY; DIABETIC FOOT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIMB SALVAGE; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; TREATMENT OUTCOME; UNNECESSARY PROCEDURES; VASCULAR SURGICAL PROCEDURES; WOUND HEALING;

EID: 70349865063     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
2. Palumbo PJ, Melton LJ III. Peripheral vascular disease and diabetes. In: National Diabetes Data Group (US), National Institute of Diabetes and Digestive and Kidney Diseases (United States), editors. Diabetes in America. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995. p. 401-408
3. Singh, N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-228 (Pubitemid 40095873)
4. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993;233:485-491 (Pubitemid 23172610)
5. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998;176:5S-10S.
6. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001;18:133-138 (Pubitemid 32238959)
7. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154
8. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456-1461
9. Fowkes FGR, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-392
10. Wrobel JS, Mayfield JA, Reiber GE. Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care 2001;24:860-4.
11. Morris AD, McAlpine R, Steinke D, Boyle DI, Ebrahim AR, Vasudev N et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998;21:738-743
12. Cronenwett JL, Warner KG, Zelenock GB, Whitehouse WM Jr, Graham LM, Lindenauer M et al. Intermittent claudication. Current results of non-operative management. Arch Surg 1984;119:430-436
13. Kannel WB, McGee DL. Update on some epidemiological features of intermittent claudication. J Am Geriatr Soc 1985;33:13-18
14. Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D. Intermittent claudication: incidence in the Framingham Study. Circulation 1970;41:875-883
15. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B. Hyperhomocystinaemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155
16. Pecoraro RE, Reiber RE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:510-521
17. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA et al. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162 (Pubitemid 29028314)
18. Braverman IM. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989;93:2S-9S.
19. Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92-102. (Pubitemid 19096380)
20. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism Sep 1983;32:943-949
21. Rayman G, Malik RA, Sharma AK, Day JL. Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients. Clin Sci (Colch) 1995;89:467-474
22. Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J (Clin Res Ed) 1986;292:1295-1298. (Pubitemid 16110004)
23. Ubbink DT, Jacobs MJ, Tangelder GJ, Slaaf DW, Reneman RS. Posturally induced microvascular constriction in patients with different stages of leg ischaemia: effect of local skin heating. Clin Sci (Colch) 1991;81:43-49
24. Jorneskog G, Brismar K, Fagrell B. Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications. Diabetologia Apr 1995;38:474-480
25. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia 1982;22:6-8.
26. Sandeman DD, Pym CA, Green EM, Seamark C, Shore AC, Tooke JE. Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients. BMJ 1991;302:1122-1123
27. Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia. Diabetologia Feb 1997;40:238-243
28. Lo Gerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984;311:1615-1619
29. Strandness DE Jr, Priest RE, Gibbons GE. Combined clinical and pathologic study of diabetic and non-diabetic peripheral arterial disease. Diabetes 1964;13:366-372
30. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001;24:1433-1437 (Pubitemid 33716433)
31. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 2001;24:335-338 (Pubitemid 32119134)
32. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Franssen MH, Schaper NC, eds. Maastricht: Schaper NC; 1999.
33. Rozema A, Ulbrecht JS, Pammer SE, Cavanagh PR. In-shoe plantar pressures during activites of daily living: implications for therapeutic footwear design. Foot Ankle Int 1996;17:352-359 (Pubitemid 26192839)
34. Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA. Is there a critical level of plantar foot pressure to identify patrients at risk for neuropathic foot ulceration? J Foot Ankle Surg 1998;37:303-307
35. Perry JE, Ulbrecht JS, Derr JA, Cavanagh PR. The use of running shoes to reduce plantar pressures in patients who have diabetes. J Bone Joint Surg Am 1995;77:1819-1828
36. Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formations, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996;13:979-982 (Pubitemid 26384122)
37. Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. QJ Med 1986;60:763-771
38. Anderson H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 2004;27:2382-2385 (Pubitemid 39281389)
39. Anderson H, Mogensen PH. Disordered mobility of large joints in association with neuropathy in patients with long-standing insulin-dependent diabetes mellitus. Diabet Med 1997;14:221-227
40. Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 1985;57:843-855 (Pubitemid 16179090)
41. Selby PL, Jude EB, Burgess J et al. Bone turnover markers in acute Charcot neuroarthropathy. Diabetologia 1998;41:A275.
42. Edelson GW, Jenson JL, Kaczynski R. Identifying acute Charcot arthropathy through urinary cross-linked N-telopeptides. Diabetes 1996;45:108A.
43. Shaw JE, Boulton AJM. The Charcot Foot. Foot 1995;5:65-70.
44. Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy (Charcot's joints) in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore) 1972;51:191-210.
45. Klenerman L. The Charcot neuroarthropathy joint in diabetes mellitus. Diabet Med 1996;13:S52-S4.
46. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435-1438 (Pubitemid 36929175)
47. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Franssen MH, Schaper NC, eds. Maastricht: Schaper NC; 1999.
48. Shearman CP, Gwynn BR, Curran F, Gannon MX, Simms MH. Non-invasive femoropopliteal assessment. Is that angiogram really necessary? Br Med J 1987;293:1086-1089
49. TASC Working Group. Definition and nomenclature for chronic critical limb ischaemia. J Vasc Surg 2000;31:73-74
50. Smith FCT, Shearman CP, Simms MH, Gwynn BR. Falsely elevated ankle pressures in severe limb ischaemia: the Pole test-an alternative approach. Eur J Vasc Surg 1994;8:408-412
51. Roedersheimer LR, Feins R, Green RM. Doppler evaluation of the pedal arch. Am J Surg 1981;142:601-604
52. Grassbaugh JA, Nelson PR, Rzucidlo EM, Schermerhorn ML, Fillinger MF, Powell RJ et al. Blinded comparison of preoperative Duplex ultrasound scanning and contrast arteriography for planning revascularisation at the level of the tibia. J Vasc Surg 2003;37:1186-1190
53. Kawasaki D, Tsujino T, Fujii K, Masutani M, Ohyanagi M, Masuyama T. Novel use of ultrasound guidance for recanalisation of iliac, femoral and popliteal arteries. Catheter Cardiovasc Interv 2008;71:727-733 (Pubitemid 351656312)
54. McCardle JE. Versajet hydroscalpel: treatment of diabetic foot infection. Br J Nurs 2006;15:S12-7.
55. Nordmyr J, Svensson S, Bjorck M, Acosta S. Vacuum assisted wound closure in patients with lower extremity arterial disease. The experience from two tertiary referral centres. Int Angiol 2009;28:26-31.
56. Pinzur MS, Shields N, Trepman E, Dawson P, Evans A. Current practice patterns in the treatment of Charcot foot. Foot Ankle Int Nov 2000;21:916-920 (Pubitemid 30951684)
57. Sammarco GJ, Conti SF. Surgical treatment of neuroarthropathic foot derformity. Foot Ankle Int 1998;19:102-109 (Pubitemid 28139131)
58. Wagner FW Jr. Amputations of the foot and ankle. Current status. Clin Orthop 1977;122:62-69
59. Pinzer MS, Sage R, Stuck R, Ketner L, Osterman H. Transcutaneous oxygen as a predictor of wound healing in amputations of the foot and ankle. Foot Ankle 1992;13:271-272
60. Pinzur MS, Kaminsky M, Sage R, Cronin R, Osterman H. Amputations at the middle level of the foot. J. Bone Joint Surg 1986;68A:1061-1064
61. Pinzur MS, Stuck R, Sage R, Hunt N, Rabinovich Z. Syme's ankle disarticulation in patients with diabetes. J Bone Joint Surg 2003;85A:1667-1672 (Pubitemid 37129599)
62. Czerny M, Trubel W, Zimpfer D, Grimm M, Koller R, Hofmann W et al. Limb salvage by femoro-distal bypass and free muscle flap transfer. Eur J Vasc Endovasc Surg 2004;27:635-639 (Pubitemid 38635006)
63. McKay C, Razik WA, Simms MH. Local anaesthetic for lower limb revascularisation in high-risk patients. Br J Surg 1997;84:1096-1098
64. Flanigan DP, Ryan TJ, Williams LR, Schwartz JA, Gray B, Schuler JJ. Aortofemoral or femoropopliteal revascularisation? A prospective evaluation of the papaverine test. J Vasc Surg 1984;1:215-223
65. Wall ML, Davies RSM, Sykes TCF, Guy AJ, Saleem J, Khera G et al. Ilio femoral pulsion endarterectomy. Ann Vasc Surg 2009;23:259-63.
66. Shearman CP, Gannon MX, Gwynn BR, Simms MH. A clinical method for the detection of arteriovenous fistulas during in situ great saphenous vein bypass. J Vasc Surg 1986;4:578-581
67. Belkin M, Knox J, Donaldson MC, Mannick JA, Whittemore AD. Infrainguinal arterial reconstruction with nonreversed greater saphenous vein. J Vasc Surg 1996;24:957-962 (Pubitemid 26425700)
68. Harris PL, Veith FJ, Shanik GD, Nott D, Wengerter KR, Moore DJ. Prospective randomised comparison of in situ and reversed infrapopliteal vein grafts. Br J Surg 1993;80:173-176 (Pubitemid 23084798)
69. Hölzenbein TJ, Pomposelli FB Jr, Miller A, Contreras MA, Gibbons GW, Campbell DR et al. Results of a policy with arm veins used as the first alternative to an available ipsilateral greater saphenous vein for infrainguinal bypass. J Vasc Surg 1996;23:130-140 (Pubitemid 26037970)
70. Smeets L, Ho GH, Haenaars T, van den Berg JC, Teijink JA, Moll FL. Remote endarterectomy: first choice in surgical treatment of long segmental SFA occlusive disease? Eur J Vasc Endovasc Surg 2003;25:583-589
71. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA et al. Six year prospective multicentre randomised comparison of autologous saphenous vein and expanded poltetrafluorethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114 (Pubitemid 16186498)
72. Stonebridge PA, Prescott RJ, Ruckley CV. Randomised trial comparing infrainguinal polytetrafluorethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. J Vasc Surg 1997;26:543-550
73. Laurila K, Lepäntalo M, Teittinen K, Kantonen I, Forssell C, Vilkko P et al. Does an adjuvant fistula improve the patency of a femorocrural PTFE bypass with distal cuff in critical leg ischaemia? - a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 2004;27:180-185 (Pubitemid 38111686)
74. Mahmood A, Garnham A, Sintler M, Smith SRG, Vohra RK, Simms MH. Composite sequential grafts for femorocrural bypass reconstruction: experience with a modified technique. J Vasc Surg 2002;36:772-778 (Pubitemid 41122975)
75. Lazaris AM, Tsiamis AC, Fishwick G, Bolia A, Bell PRF. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischaemia. J Endovasc Ther 2004;11:447-453 (Pubitemid 39096342)
76. Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1 000 cases. J Vasc Surg 2003;37:307-315 (Pubitemid 36236907)
77. Reed AB, Conte MS, Belkin M, Mannick JA, Whittemore AD, Donaldson MC. Usefulness of autogenous bypass grafts originating distal to the groin. J Vasc Surg 2002;35:48-54. (Pubitemid 44725770)
78. Hickey NC, Shearman CP, Crowson MC, Simms MH, Watson H. Iloprost improves femoro-distal graft flow after a single bolus injection. Eur J Vasc Surg 1991;5:19-22.
79. Wölfle KD, Bruijnen H, Loeprecht H, Rümenapf G, Schweiger H, Grabitz K et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg 2003;25:229-234 (Pubitemid 36527616)
80. Gu YQ, Zhang J, Qi LX, Yu HX, Li JX, Li XF et al. Surgical treatment of 82 patients with diabetic lower limb ischaemia by distal arterial bypass. Chin Med J (Engl) 2007;120:106-109 (Pubitemid 46584906)
81. Shah DM, Darling RC III, Chang BB, Fitzgerald KM, Paty PS, Leather RP. Long term results of in situ saphenous vein bypass. Analysis of 2 058 cases. Ann Surg 1995;222:438-446
82. Faglia E, Clerici G, Mantero M, Caminiti M, Quarantiello A, Curci V et al. Incidence of critical limb ischaemia and amputation outcome in contralateral limb in diabetic patients hospitalized for unilateral critical limb ischemia during 1999-2003 and followed up until 2005. Diabetes Res Clin Pract 2007;77:445-450
83. Lantis J, Jensen M, Benvenisty A, Mendes D, Gendics C, Todd G. Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss. Ann Vasc Surg 2008;22:366-371 (Pubitemid 351615265)
84. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al.; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934.